About Trivascular Technologies (NASDAQ:TRIV)
Trivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.
Industry, Sector and Symbol
Industry Medical Devices & Implants
SectorMedical Devices & Implants
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-766.90%
Return on Assets-66.97%
Trivascular Technologies (NASDAQ:TRIV) Frequently Asked Questions
What is Trivascular Technologies' stock symbol?
Trivascular Technologies trades on the NASDAQ under the ticker symbol "TRIV."
How were Trivascular Technologies' earnings last quarter?
Trivascular Technologies Inc (NASDAQ:TRIV) announced its quarterly earnings results on Monday, November, 9th. The medical device company reported ($0.66) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.71) by $0.05. The medical device company had revenue of $9.50 million for the quarter, compared to analyst estimates of $9.28 million. Trivascular Technologies had a negative net margin of 143.61% and a negative return on equity of 766.90%. The firm's revenue was up 20.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.69) earnings per share. View Trivascular Technologies' Earnings History.
Who are some of Trivascular Technologies' key competitors?
How do I buy Trivascular Technologies stock?
Shares of Trivascular Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Trivascular Technologies' stock price today?
One share of Trivascular Technologies stock can currently be purchased for approximately $5.87.
How big of a company is Trivascular Technologies?
Trivascular Technologies has a market capitalization of $120.75 million.
How can I contact Trivascular Technologies?
Trivascular Technologies' mailing address is 3910 Brickway Blvd, SANTA ROSA, CA 95403-1070, United States. The medical device company can be reached via phone at +1-707-5438800.
MarketBeat Community Rating for Trivascular Technologies (TRIV)MarketBeat's community ratings are surveys of what our community members think about Trivascular Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Trivascular Technologies (NASDAQ:TRIV) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Trivascular Technologies (NASDAQ:TRIV) Earnings History and Estimates Chart
Trivascular Technologies (NASDAQ TRIV) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/9/2015||Q3||($0.71)||($0.66)||$9.28 million||$9.50 million||View||N/A|
|8/4/2015||Q215||($0.73)||($0.73)||$8.78 million||$9.70 million||View||N/A|
|5/5/2015||Q115||($0.68)||($0.77)||$8.48 million||$9.00 million||View||Listen|
|3/3/2015||Q414||($0.65)||($0.72)||$9.54 million||$9.10 million||View||Listen|
|11/10/2014||Q314||($0.63)||($0.69)||$7.90 million||$7.88 million||View||N/A|
|8/6/2014||Q214||($0.66)||($0.87)||$7.54 million||$7.80 million||View||N/A|
|5/14/2014||Q1 14||($1.10)||($1.17)||$6.90 million||$7.00 million||View||N/A|
Trivascular Technologies (NASDAQ:TRIV) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Trivascular Technologies (NASDAQ:TRIV)
No dividend announcements for this company have been tracked by MarketBeat.com
Trivascular Technologies (NASDAQ TRIV) Insider Trading and Institutional Ownership History
Trivascular Technologies (NASDAQ TRIV) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/22/2014||Douglas A Roeder||Director||Buy||833,333||$12.00||$9,999,996.00|| |
|4/22/2014||Enterprise Associates 12 New||Major Shareholder||Buy||583,333||$12.00||$6,999,996.00|| |
|4/22/2014||James E Flynn||Insider||Buy||1,065,000||$12.01||$12,790,650.00|| |
Trivascular Technologies (NASDAQ TRIV) News Headlines
Trivascular Technologies (NASDAQ:TRIV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Trivascular Technologies (NASDAQ TRIV) Stock Chart for Saturday, December, 16, 2017